NO20003112L - Aryltiazolidinonderivater - Google Patents

Aryltiazolidinonderivater

Info

Publication number
NO20003112L
NO20003112L NO20003112A NO20003112A NO20003112L NO 20003112 L NO20003112 L NO 20003112L NO 20003112 A NO20003112 A NO 20003112A NO 20003112 A NO20003112 A NO 20003112A NO 20003112 L NO20003112 L NO 20003112L
Authority
NO
Norway
Prior art keywords
aryltiazolidinonderivater
pparα
thiazolidinediones
hypertriglyceridemia
ppar
Prior art date
Application number
NO20003112A
Other languages
English (en)
Other versions
NO20003112D0 (no
Inventor
Soumya P Sahoo
Richard L Tolman
Wei Han
Jeffrey Bergmann
Conrad Santini
Vicki R Lombardo
Ranjit Desai
Julia K Boueres
Dominick F Gratale
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9816279.5A external-priority patent/GB9816279D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO20003112D0 publication Critical patent/NO20003112D0/no
Publication of NO20003112L publication Critical patent/NO20003112L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Substituerte 5-aryl-2,4- tiazolidindioner er kraftige antagon- ister av PPAR, og er derfor anvendbare ved behandling, kontroll eller fore- byggelse av diabetes, hyperglykemi, hyperlipidemi (innbefattet hyperkoles- terolemi og hypertriglyseridemi), aterosklerose, fedme, vaskulær resten- ose og andre sykdommer, forstyrrelser eller tilstander som formidles av PPARa, p og/eller y.
NO20003112A 1997-12-19 2000-06-16 Aryltiazolidinonderivater NO20003112L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6827197P 1997-12-19 1997-12-19
GBGB9816279.5A GB9816279D0 (en) 1998-07-27 1998-07-27 Arylthiazolidinedione derivatives
US10523898P 1998-10-22 1998-10-22
PCT/US1998/027139 WO1999032465A1 (en) 1997-12-19 1998-12-18 Arylthiazolidinedione derivatives

Publications (2)

Publication Number Publication Date
NO20003112D0 NO20003112D0 (no) 2000-06-16
NO20003112L true NO20003112L (no) 2000-08-18

Family

ID=27269416

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003112A NO20003112L (no) 1997-12-19 2000-06-16 Aryltiazolidinonderivater

Country Status (21)

Country Link
EP (1) EP1040102B1 (no)
JP (1) JP3373198B2 (no)
KR (1) KR20010033355A (no)
CN (1) CN1282325A (no)
AT (1) ATE352545T1 (no)
AU (1) AU740733B2 (no)
BG (1) BG104602A (no)
BR (1) BR9813801A (no)
CA (1) CA2315397C (no)
DE (1) DE69836980T2 (no)
EA (1) EA200000687A1 (no)
ES (1) ES2281146T3 (no)
HU (1) HUP0101366A2 (no)
ID (1) ID24878A (no)
IL (1) IL136138A0 (no)
IS (1) IS5506A (no)
NO (1) NO20003112L (no)
PL (1) PL340958A1 (no)
SK (1) SK9212000A3 (no)
TR (1) TR200001753T2 (no)
WO (1) WO1999032465A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824614D0 (en) * 1998-11-11 1999-01-06 Glaxo Group Ltd Chemical compounds
EP1053989B1 (en) * 1999-05-20 2007-07-25 Ciba SC Holding AG Hydroxydiphenyl ether compounds
CA2376919C (en) * 1999-06-18 2008-11-04 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
AU5876900A (en) * 1999-06-18 2001-01-09 Merck & Co., Inc. Process for making arylthiazolidinedione derivatives
AU7073400A (en) * 1999-08-27 2001-03-26 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
PL356745A1 (en) * 1999-11-10 2004-06-28 Takeda Chemical Industries, Ltd Body weight gain inhibitors
AU2001298065A1 (en) * 2001-01-12 2003-09-02 Abbott Laboratories Process for the preparation of matrix metalloproteinase inhibitors
US20040077689A1 (en) * 2001-04-25 2004-04-22 Yasuo Sugiyama Abc expression promoters
AU2003256655A1 (en) * 2002-07-25 2004-02-16 Merck And Co., Inc. Therapeutic compounds for treating dyslipidemic conditions
PL378268A1 (pl) * 2002-11-26 2006-03-20 Pfizer Products Inc. Aktywatory PPAR
CN1319956C (zh) * 2003-09-12 2007-06-06 深圳市海粤门生物科技开发有限公司 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用
DE602004022179D1 (de) * 2003-09-19 2009-09-03 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyessigsäuren und analoga
HUE028213T2 (en) 2003-09-19 2016-12-28 Janssen Pharmaceutica Nv 4 - ((Phenoxyalkyl) thio) -phenoxyacetic acid for use in the treatment of PPAR-delta-mediated conditions
EP1709014B1 (en) * 2004-01-20 2007-05-30 Merck & Co., Inc. Antidiabetic oxazolidinediones and thiazolidinediones
WO2006138328A1 (en) * 2005-06-14 2006-12-28 Merck & Co., Inc. Process for the production of antidiabetic oxazolidinediones
US7807692B2 (en) 2005-07-06 2010-10-05 Merck Sharp & Dohme Corp. Antidiabetic oxazolidinediones and thiazolidinediones
US20090069385A1 (en) * 2005-07-20 2009-03-12 Meinke Peter T Antidiabetic Oxazolidinediones and Thiazolidinediones
US7858666B2 (en) 2007-06-08 2010-12-28 Mannkind Corporation IRE-1α inhibitors
CN105001174A (zh) * 2015-07-14 2015-10-28 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端腈基苄基类结构的化合物及其用途
CN104987314A (zh) * 2015-07-14 2015-10-21 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端硝基苄基类结构的化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3053490B2 (ja) * 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−２，４−ジオン誘導体とその塩及び製造法
JP3906935B2 (ja) * 1995-12-18 2007-04-18 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
ES2202582T3 (es) * 1996-02-02 2004-04-01 MERCK & CO., INC. Agentes antidiabeticos.
WO1997028137A1 (en) * 1996-02-02 1997-08-07 Merck & Co., Inc. Heterocyclic derivatives as antidiabetic and antiobesity agents
DE69728267T2 (de) * 1996-02-02 2005-02-24 Merck & Co., Inc. Antidiabetisches mittel
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CN1282325A (zh) 2001-01-31
PL340958A1 (en) 2001-03-12
NO20003112D0 (no) 2000-06-16
IS5506A (is) 2000-05-23
EA200000687A1 (ru) 2000-12-25
ID24878A (id) 2000-08-31
DE69836980D1 (de) 2007-03-15
ATE352545T1 (de) 2007-02-15
SK9212000A3 (en) 2001-02-12
JP3373198B2 (ja) 2003-02-04
CA2315397C (en) 2007-08-07
HUP0101366A2 (hu) 2001-09-28
CA2315397A1 (en) 1999-07-01
EP1040102A1 (en) 2000-10-04
EP1040102B1 (en) 2007-01-24
AU740733B2 (en) 2001-11-15
EP1040102A4 (en) 2002-11-27
BG104602A (bg) 2001-01-31
JP2001526278A (ja) 2001-12-18
ES2281146T3 (es) 2007-09-16
KR20010033355A (ko) 2001-04-25
AU1833499A (en) 1999-07-12
WO1999032465A1 (en) 1999-07-01
IL136138A0 (en) 2001-05-20
BR9813801A (pt) 2000-10-03
TR200001753T2 (tr) 2000-11-21
DE69836980T2 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
NO20003112L (no) Aryltiazolidinonderivater
EP1194146A4 (en) ARYLTHIAZOLIDINEDIONE AND ARYLOXA ZOLIDINEDION DERIVATIVES
AU7705601A (en) N-substituted indoles useful in the treatment of diabetes
WO2002026729A3 (en) Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
WO2002064094A3 (en) 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
WO2004066963A3 (en) N-cyclohexylaminocarbonyl benzenesulfonamide derivatives
NO20015607D0 (no) Glukagonantagonister/inversagonister
NO20075000L (no) Kondenserte aromatiske forbindelser med anti-diabetisk aktivitet
DK0546076T3 (da) Anvendelse af anti-ICAM antistoffer til fremstilling af et lægemiddel til behandling af endotoksiskshock
ATE242179T1 (de) Verfahren und vorrichtung zum homogenen erwärmen von gläsern und/oder glaskeramiken mit hilfe von infrarot-strahlung
NO305377B1 (no) Svingd°r
ECSP993022A (es) Derivados de ariltiazolidindiona
ES2173180T3 (es) Derivados del mercaptoacetilamida hipocolesterolemicos, antiateroescleroticos e hipotrigliceridemicos.
DK0458892T3 (da) Anvendelse af chlormethiazol ved fremstillingen af et medikament til forebyggelsen og/eller behandlingen af neurodegeneration
AR018898A1 (es) Derivados de 5-aril-2,4-tiazolidindiona, una composicion farmaceutica que los comprende y el uso de los mismos para la fabricacion de un medicamento
DK0463063T3 (da) Hængselforbundet lamineret genstand
NO963988D0 (no) Hypokolesterolemiske-, antiatherosklerotiske-, og hypotriglyceridemiske mercaptoacetylamidderivater
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.
DOP2001000256A (es) Derivados del acidobenzopirancarboxilico para el tratamineto de la diabetes y los trastornos de lipidos.
DK1032490T3 (da) Fremgangsmåde ved termo-mekanisk behandling af naturtræ, som er beskadiget eller vandfyldt og det således tilvejebragte produkt
NO905292L (no) Fremgangsmaate for behandling av slam som oppstaar ved elektroplettering av metaller.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application